Outcome differences in acute vs. acute on chronic heart failure and cardiogenic shock
Abstract Aims Despite advances in coronary reperfusion and percutaneous mechanical circulatory support, mortality among patients presenting with cardiogenic shock (CS) remains unacceptably high. Clinical trials and risk stratification tools have largely focused on acute CS, particularly secondary to...
Main Authors: | Tara L. Jones, Michael C. Tan, Vidang Nguyen, Kathleen E. Kearney, Charles C. Maynard, Emily Anderson, Claudius Mahr, James M. McCabe |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-06-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.12670 |
Similar Items
-
Long-Term Clinical Outcome of Cardiogenic Shock Patients Undergoing Impella CP Treatment vs. Standard of Care
by: Clemens Scherer, et al.
Published: (2020-11-01) -
Impact of Age on Outcomes in Patients With Cardiogenic Shock
by: Manreet Kanwar, et al.
Published: (2021-07-01) -
Patient Characteristics, Treatment and Outcome in Non-Ischemic vs. Ischemic Cardiogenic Shock
by: Benedikt Schrage, et al.
Published: (2020-03-01) -
Contemporary Management of Cardiogenic Shock Complicating Acute Myocardial Infarction
by: Leonardo De Luca, et al.
Published: (2023-03-01) -
Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock
by: Jacob Eifer Møller, et al.
Published: (2022-04-01)